Literature DB >> 11678426

PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis.

S Izumoto1, T Ohnishi, H Kanemura, N Arita, M Maruno, T Moriuchi, S Suzuki, T Yoshimine.   

Abstract

A putative tumor suppressor, the PTEN gene at chromosome 10q23. was identified and found to be mutated in many different human tumors. PTEN was recently found to be also involved in focal cell adhesion and cell migration. To identify the role of PTEN gene in malignant gliomas. we used PCR-SSCP and direct sequencing methods to examine 44 malignant gliomas comprising 29 cases without and 15 cases with meningeal gliomatosis. In malignant gliomas without meningeal gliomatosis, 2/29 (7%) of the cases showed alteration of the PTEN gene. In contrast, 5/15 (33%) of malignant gliomas with meningeal gliomatosis cases showed this alteration. These findings indicate that PTEN gene mutation contributes not only to the neoplastic evolution in gliomas but also to the meningeal dissemination of glioma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678426     DOI: 10.1023/a:1011839920176

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  PTEN1 is frequently mutated in primary endometrial carcinomas.

Authors:  D Kong; A Suzuki; T T Zou; A Sakurada; L W Kemp; S Wakatsuki; T Yokoyama; H Yamakawa; T Furukawa; M Sato; N Ohuchi; S Sato; J Yin; S Wang; J M Abraham; R F Souza; K N Smolinski; S J Meltzer; A Horii
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

Review 2.  Tensin: a potential link between the cytoskeleton and signal transduction.

Authors:  S H Lo; E Weisberg; L B Chen
Journal:  Bioessays       Date:  1994-11       Impact factor: 4.345

3.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

4.  DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.

Authors:  J Mollenhauer; S Wiemann; W Scheurlen; B Korn; Y Hayashi; K K Wilgenbus; A von Deimling; A Poustka
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

5.  Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.

Authors:  J Boström; J M Cobbers; M Wolter; G Tabatabai; R G Weber; P Lichter; V P Collins; G Reifenberger
Journal:  Cancer Res       Date:  1998-01-01       Impact factor: 12.701

6.  PTEN gene mutations are seen in high-grade but not in low-grade gliomas.

Authors:  B K Rasheed; T T Stenzel; R E McLendon; R Parsons; A H Friedman; H S Friedman; D D Bigner; S H Bigner
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

7.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

8.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

9.  Clinical outcome in aggressively treated meningeal gliomatosis.

Authors:  R Grant; B Naylor; L Junck; H S Greenberg
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

10.  Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.

Authors:  K Ueda; M Nishijima; H Inui; M Watatani; E Yayoi; J Okamura; M Yasutomi; Y Nakamura; Y Miyoshi
Journal:  Jpn J Cancer Res       Date:  1998-01
View more
  7 in total

1.  A case report and review of the literature.

Authors:  Shoji Yomo; Tsuyoshi Tada; Shuichi Hirayama; Naoko Tachibana; Masako Otani; Yuichiro Tanaka; Kazuhiro Hongo
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

2.  Mechanistic analysis of a DNA damage-induced, PTEN-dependent size checkpoint in human cells.

Authors:  Jung-Sik Kim; Xuehua Xu; Huifang Li; David Solomon; William S Lane; Tian Jin; Todd Waldman
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

3.  PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.

Authors:  Ru-Bin Cheng; Rui-Juan Ma; Zhao-Kai Wang; Shan-Jun Yang; Xiang-Zhi Lin; Hui Rong; Yong Ma
Journal:  Mol Cell Biochem       Date:  2010-11-26       Impact factor: 3.396

Review 4.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

5.  Association of stem cell marker CD133 expression with dissemination of glioblastomas.

Authors:  Atsushi Sato; Kaori Sakurada; Toshihiro Kumabe; Toshio Sasajima; Takaaki Beppu; Kenichiro Asano; Hiroki Ohkuma; Akira Ogawa; Kazuo Mizoi; Teiji Tominaga; Chifumi Kitanaka; Takamasa Kayama
Journal:  Neurosurg Rev       Date:  2010-02-05       Impact factor: 3.042

6.  Pediatric Giant Cell Glioblastoma Presenting with Intracranial Dissemination at Diagnosis: A Case Report.

Authors:  Takamasa Kinoshita; Hirohito Yano; Noriyuki Nakayama; Natsuko Suzui; Tomohiro Iida; Saori Endo; Shiho Yasue; Michio Ozeki; Kazuhiro Kobayashi; Tatsuhiko Miyazaki; Toru Iwama
Journal:  NMC Case Rep J       Date:  2021-06-05

7.  Surgical Ventricular Entry is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas.

Authors:  Roland Roelz; Peter Reinacher; Ramazan Jabbarli; Rainer Kraeutle; Beate Hippchen; Karl Egger; Astrid Weyerbrock; Marcia Machein
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.